Inhibition by apple polyphenols of ADP-ribosyltransferase activity of cholera toxin and toxin-induced fluid accumulation in mice

被引:45
|
作者
Saito, T
Miyake, M
Toba, M
Okamatsu, H
Shimizu, S
Noda, M
机构
[1] Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chuo Ku, Chiba 2608670, Japan
[2] Otsuka Pharmaceut Co Ltd, Otsu Nutraceut Res Inst, Otsu, Shiga 520002, Japan
[3] Otsuka Pharmaceut Co Ltd, P14 Project, Osaka 5400021, Japan
关键词
apple polyphenols; cholera toxin; ADP-ribosyltransferase; fluid accumulation;
D O I
10.1111/j.1348-0421.2002.tb02693.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effects of crude polyphenol extracted from immature apples on the enzymatic and biological activities of a cholera toxin (CT) were investigated. When the apple polyphenol extract (APE) was examined for properties to inhibit CT-catalyzed ADP-ribosylation of agmatine, it was found that APE inhibited it in a dose-dependent manner. The concentration of APE to inhibit 50% of the enzymatic activity of CT (15 mug/ml) was approximately 8.7 mug/ml. The APE also diminished CT-induced fluid accumulation in two diarrhea models for in vivo mice. In the ligated ileum loops, 25 jig of APE significantly inhibited fluid accumulation induced by 500 ng of CT. In a sealed mouse model, even when APE was administered orally 10 min after a toxin injection, fluid accumulation was significantly inhibited at a comparable dosage. Lineweaver-Burk analysis demonstrated that APE had negative allosteric effects on CT-catalyzed NAD: agmatine ADP-ribosyltransferase. We fractionated the APE into four fractions using LH-20 Sephadex resin. One of the fractions, FAP (fraction from apple polyphenol) 1, which contains non-catechin polyphenols, did not significantly inhibit the CT-catalyzed ADP-ribosylation of agmatine. FAP2, which contains compounds with monomeric, dimeric, and trimeric catechins, inhibited the ADP-ribosylation only partially, but significantly. FAP3 and FAP4, which consist of highly polymerized catechin compounds, strongly inhibited the ADP-ribosylation, indicating that the polymerized structure of catechin is responsible for the inhibitory effect that resides in APE. The results suggest that polymerized catechin compounds in APE inhibit the biological and enzymatic activities of CT and can be used in a precautionary and therapeutic manner in the treatment of cholera patients.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 50 条
  • [2] THE ADP-RIBOSYLTRANSFERASE ACTIVITY OF CHOLERA-TOXIN AND ESCHERICHIA-COLI HEAT-LABILE TOXIN
    COULSON, CJ
    NASSAU, PM
    TAIT, RM
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1984, 12 (02) : 184 - 187
  • [3] CHOLERA-TOXIN AND PERTUSSIS TOXIN SUBSTRATES AND ENDOGENOUS ADP-RIBOSYLTRANSFERASE ACTIVITY IN DROSOPHILA-MELANOGASTER
    HOPKINS, RS
    STAMNES, MA
    SIMON, MI
    HURLEY, JB
    BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 970 (03) : 355 - 362
  • [4] An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice
    Izzo, AA
    Capasso, F
    Costagliola, A
    Bisogno, T
    Marsicano, G
    Ligresti, A
    Matias, I
    Capasso, R
    Pinto, L
    Borrelli, F
    Cecio, A
    Lutz, B
    Mascolo, N
    Di Marzo, V
    GASTROENTEROLOGY, 2003, 125 (03) : 765 - 774
  • [5] ADP-RIBOSYLATION OF A(1) PEPTIDE OF CHOLERA-TOXIN BY CHICKEN ARGININE-SPECIFIC ADP-RIBOSYLTRANSFERASE WITH A CONCOMITANT INCREASE IN ADP-RIBOSYLTRANSFERASE ACTIVITY OF THE PEPTIDE
    TERASHIMA, M
    SHIMOYAMA, M
    BIOMEDICAL RESEARCH-TOKYO, 1993, 14 (05): : 329 - 335
  • [6] Discovery of Compounds Inhibiting the ADP-Ribosyltransferase Activity of Pertussis Toxin
    Ashok, Yashwanth
    Miettinen, Moona
    de Oliveira, Danilo Kimio Hirabae
    Tamirat, Mahlet Z.
    Nareoja, Katja
    Tiwari, Avlokita
    Hottiger, Michael O.
    Johnson, Mark S.
    Lehtio, Lari
    Pulliainen, Arto T.
    ACS INFECTIOUS DISEASES, 2020, 6 (04): : 588 - 602
  • [7] THIOL REAGENTS ARE SUBSTRATES FOR THE ADP-RIBOSYLTRANSFERASE ACTIVITY OF PERTUSSIS TOXIN
    LOBBAN, MD
    VANHEYNINGEN, S
    FEBS LETTERS, 1988, 233 (02) : 229 - 232
  • [8] Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity
    Yamamoto, S
    Takeda, Y
    Yamamoto, M
    Kurazono, H
    Imaoka, K
    Yamamoto, M
    Fujihashi, K
    Noda, M
    Kiyono, H
    McGhee, JR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (07): : 1203 - 1210
  • [9] ADP-RIBOSYLTRANSFERASE ACTIVITY OF PERTUSSIS TOXIN AND IMMUNOMODULATION BY BORDETELLA-PERTUSSIS
    BLACK, WJ
    MUNOZ, JJ
    PEACOCK, MG
    SCHAD, PA
    COWELL, JL
    BURCHALL, JJ
    LIM, M
    KENT, A
    STEINMAN, L
    FALKOW, S
    SCIENCE, 1988, 240 (4852) : 656 - 659
  • [10] Competitive inhibiton of mosquitocidal toxin ADP-ribosyltransferase activity by an internal peptide
    Carpusca, I
    Schirmer, J
    Aktories, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R15 - R15